Drug Use Investigation for REVOLADE (ITP)
NCT01416311
·
clinicaltrials.gov ↗
COMPLETED
Status
5797
Enrollment
INDUSTRY
Sponsor class
Conditions
Purpura, Thrombocytopaenic, Idiopathic
Interventions
DRUG:
Eltrombopag
Sponsor
Novartis Pharmaceuticals